Nanosphere, which markets a platform for molecular diagnostic testing, priced its 7 million share offering at the low end of the $14-$16 range Wednesday evening. Credit Suisse was the bookrunner on the deal. The stock is expected to begin trading Thursday on the NASDAQ under the ticker "NSPH."
